JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Back, W.
Right arrow Articles by Bleyl, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Back, W.
Right arrow Articles by Bleyl, U.
Right arrowPubmed/NCBI databases
*Substance via MeSH
*Genetics Home Reference
Journal of Clinical Pathology 1999;52:345-349
© 1999 Journal of Clinical Pathology


ARTICLES

Immunolocalization of beta catenin in intestinal polyps of Peutz- Jeghers and juvenile polyposis syndromes

W Back, S Loff, D Jenne and U Bleyl
Department of Pathology, Klinikum Mannheim, University of Heidelberg, Germany. walter.back@path.ma.uni-heidelberg.de

AIM: To examine the membranous and nuclear distribution of beta catenin in the epithelial cells of gut polyps from Peutz-Jeghers syndrome and juvenile polyposis in comparison with other types of polyps and tumours. METHODS: Immunohistochemistry for beta catenin and proliferation markers was performed on conventional paraffin sections. Immunohistological staining was carried out on Peutz-Jeghers syndrome polyps from four different families, on juvenile polyposis polyps from two different families, on solitary juvenile polyps, and on hyperplastic polyps. The immunohistochemistry was evaluated qualitatively in relation to defined areas of the polyps. RESULTS: All polyps from the hamartomatous polyposis syndromes (Peutz-Jeghers syndrome and juvenile polyposis) showed nuclear localization of beta catenin in some epithelial cell nuclei. In Peutz-Jeghers syndrome polyps beta catenin positive nuclei were seen at the base of the deep crypt infoldings. In juvenile polyposis polyps and in some solitary juvenile polyps they were found in irregularly distributed cryptal epithelial cells corresponding to the proliferative compartments. Normal mucosa of the gut and hyperplastic polyps of the colon do not show nuclear staining for beta catenin. CONCLUSIONS: The dysregulation of cellular beta catenin distribution is not only a phenomenon of adenoma formation and adenoma progression in the colon--it is at least focally present in polyps of the hamartomatous type and is related to the proliferation zones of these polyps. The nuclear translocation of beta catenin most probably reflects a disturbed beta catenin metabolism. In view of the different functions of beta catenin during development and cell differentiation, the nuclear translocation of beta catenin is likely to be an important factor in enhanced cell proliferation which escapes local control mechanisms.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. C. C. Wong, E. S. F. Lo, K. C. Lee, J. K. C. Chan, and W. L. W. Hsiao
Prognostic and Diagnostic Significance of {beta}-Catenin Nuclear Immunostaining in Colorectal Cancer
Clin. Cancer Res., February 15, 2004; 10(4): 1401 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
S C C Wong, E S F Lo, A K C Chan, K C Lee, and W L Hsiao
Nuclear {beta} catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong
Mol. Pathol., December 1, 2003; 56(6): 347 - 352.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M J Pukkila, J A Virtaniemi, E J Kumpulainen, R T Pirinen, R T Johansson, H J Valtonen, M T Juhola, and V-M Kosma
Nuclear {beta} catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma
J. Clin. Pathol., January 1, 2001; 54(1): 42 - 47.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.